RecallGuardianCanada
Drugs· Updated February 15, 2012

CAPRELSA (vandetanib) - Serious Risk of Abnormal Heart Rhythm - For Health Professionals

Critical priority
Where it was sold

ONReported in the official notice — confirm there.

Issued by

Health Canada — Marketed health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls